| Prostate Cancer |
1 |
1 |
| Metastasis |
0 |
0.55 |
| Radiation Therapy |
0 |
0.99 |
| Radical Prostatectomy |
0 |
0.98 |
| Cancer |
0 |
0.48 |
| Prostate |
0 |
0.41 |
| Prostatectomy |
0 |
0.41 |
| Toxicology |
0 |
0.36 |
| Lymph Node |
0 |
0.28 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.21 |
| Care and Maintenance of Vision |
0 |
0.17 |
| Hypertension |
0 |
0.12 |
| Cataract |
0 |
0.11 |
| A-Scan Biometry |
0 |
0.07 |
| California |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Controlled Hypertension |
0 |
0.07 |
| Diarrhea |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Fatigue |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Medical Oncology |
0 |
0.07 |
| Postoperative |
0 |
0.07 |
| Scan |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Washington |
0 |
0.07 |